The personal pain goal is inadequate for assessing outcomes of cancer pain management; goals should include function, medication effects, and safety. Cancer patients need a more comprehensive means of ...

Breast cancer remains a predominant global health challenge for women, with late-stage diagnosis being a key contributor to its high mortality. This is particularly pronounced in low-resource settings ...

In imaging, AI systems have demonstrated superior accuracy in breast cancer screening and skin lesion classification, often surpassing experienced clinicians. AI revolutionizes cancer care by ...

Large cell carcinoma is aggressive, requiring early detection through imaging and biopsy for optimal treatment outcomes.

mCRC treatment involves balancing efficacy, tolerability, and patient goals, with fruquintinib, regorafenib, and trifluridine-tipiracil as key therapies. Oncology pharmacists are essential in ...

The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...

Cancer continues to be employers' biggest treatment cost, driving up healthcare spending. Costs for cancer-related medical services and drugs are expected to reach nearly $250 billion in the U.S. by ...

Laryngeal cancer represents a complex clinical entity where the dual goals of oncologic control and functional preservation are paramount. With evolving ...

The intricate relationship between diet, metabolic disorders, and cancer progression has garnered significant attention in ...

Cancer cachexia is a complex metabolic syndrome characterized by the ongoing loss of skeletal muscle mass, with or without fat loss, that cannot be reversed entirely by conventional nutritional ...